These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20662842)

  • 1. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.
    Bordin L; Fiore C; Zen F; Coleman MD; Ragazzi E; Clari G
    Br J Pharmacol; 2010 Nov; 161(5):1186-99. PubMed ID: 20662842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.
    Bian Y; Kim K; An GJ; Ngo T; Bae ON; Lim KM; Chung JH
    Toxicol Sci; 2019 Dec; 172(2):435-444. PubMed ID: 31428780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes.
    Grossman SJ; Simson J; Jollow DJ
    Toxicol Appl Pharmacol; 1992 Dec; 117(2):208-17. PubMed ID: 1471153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.
    Albuquerque RV; Malcher NS; Amado LL; Coleman MD; Dos Santos DC; Borges RS; Valente SA; Valente VC; Monteiro MC
    PLoS One; 2015; 10(8):e0134768. PubMed ID: 26284371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometriosis Susceptibility to Dapsone-Hydroxylamine-Induced Alterations Can Be Prevented by Licorice Intake: In Vivo and In Vitro Study.
    Sabbadin C; Andrisani A; Donà G; Tibaldi E; Brunati AM; Dall'Acqua S; Ragazzi E; Ambrosini G; Armanini D; Bordin L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glycyrrhetinic acid on membrane band 3 in human erythrocytes.
    Fiore C; Bordin L; Pellati D; Armanini D; Clari G
    Arch Biochem Biophys; 2008 Nov; 479(1):46-51. PubMed ID: 18778682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes.
    McMillan DC; Simson JV; Budinsky RA; Jollow DJ
    J Pharmacol Exp Ther; 1995 Jul; 274(1):540-7. PubMed ID: 7616443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes.
    Minetti G; Piccinini G; Balduini C; Seppi C; Brovelli A
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):445-50. PubMed ID: 8973551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone hydroxylamine-mediated alterations in human red blood cells from endometriotic patients.
    Andrisani A; Donà G; Sabbadin C; Dall'Acqua S; Tibaldi E; Roveri A; Bosello Travain V; Brunati AM; Ambrosini G; Ragazzi E; Armanini D; Bordin L
    Gynecol Endocrinol; 2017 Dec; 33(12):928-932. PubMed ID: 28557604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipid peroxidation in dapsone-induced hemolytic anemia.
    McMillan DC; Jensen CB; Jollow DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):868-76. PubMed ID: 9864266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro.
    Coleman MD; Holden LJ
    Environ Toxicol Pharmacol; 2004 May; 17(1):55-9. PubMed ID: 21782713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of glyceraldehyde 3 phosphate dehydrogenase activity and tyr-phosphorylation of Band 3 in human erythrocytes treated with ferriprotoporphyrin IX.
    Omodeo-Salè F; Cortelezzi L; Riva E; Vanzulli E; Taramelli D
    Biochem Pharmacol; 2007 Nov; 74(9):1383-9. PubMed ID: 17714694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3.
    Ferru E; Giger K; Pantaleo A; Campanella E; Grey J; Ritchie K; Vono R; Turrini F; Low PS
    Blood; 2011 Jun; 117(22):5998-6006. PubMed ID: 21474668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of anti-band 3 autoantibody to oxidatively damaged erythrocytes. Formation of senescent antigen on erythrocyte surface by an oxidative mechanism.
    Beppu M; Mizukami A; Nagoya M; Kikugawa K
    J Biol Chem; 1990 Feb; 265(6):3226-33. PubMed ID: 2303447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sorting of tyrosine kinases and phosphotyrosine phosphatases acting on band 3 during vesiculation of human erythrocytes.
    Minetti G; Ciana A; Balduini C
    Biochem J; 2004 Jan; 377(Pt 2):489-97. PubMed ID: 14527338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone toxicity: some current perspectives.
    Coleman MD
    Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine.
    Bradshaw TP; McMillan DC; Crouch RK; Jollow DJ
    Free Radic Biol Med; 1997; 22(7):1183-93. PubMed ID: 9098092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
    Grossman SJ; Jollow DJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.